Incannex’s Breakthrough Chewing Gum Aids Smoking Cessation
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
- Latest
- Trending
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
Bitcoin breaks above $50,000 for the first time in over two years, signaling a potent resurgence. Analysts predict a potential ...
XRP's fall from the second-largest cryptocurrency to sixth position in market cap sparks concern, but there are speculations about its ...
Atria Wealth Solutions Inc. has increased its stake in the First Trust Nasdaq Artificial Intelligence and Robotics ETF, along with ...
Procore Technologies exceeds $1 billion in annual recurring revenue in Q4 FY 2023, demonstrating resilience and setting a positive outlook ...
Bitcoin's surge above $50,000, despite a strong dollar and rising Treasury yields, suggests a significant shift in momentum driven by ...
The global commodities market shows mixed performances, reflecting cautious optimism and potential concerns, amidst evolving factors and future uncertainties.
Children today are growing up more slowly than previous generations due to the impact of technology on their childhood and ...
Aave (AAVE) and Mina (MINA) surge in value, reflecting growing interest in digital assets. AAVE projected to reach $139.85 by ...
Digital Realty's strong Q4 2023 results and plans for 2024, including new ventures and capital recycling efforts, point to continued ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.